Trust Company of Vermont’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Trust Company of Vermont’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200	Closed	-$35K	–	849
2015 Q1	$35K	Hold	200	–	–	0.01%	453
2014 Q4	$23K	Hold	200	–	–	﹤0.01%	526
2014 Q3	$31K	Hold	200	–	–	﹤0.01%	474
2014 Q2	$25K	Hold	200	–	–	﹤0.01%	495
2014 Q1	$21K	Buy	+200	New	+$20.5K	﹤0.01%	511

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Trust Company of Vermont's SLXP Position: Q2 2015 in Review

Trust Company of Vermont sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 200 shares — an estimated $35K sold.

Trust Company of Vermont first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $35K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Trust Company of Vermont reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Trust Company of Vermont sold 200 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $35K.
Trust Company of Vermont first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 5 quarters.
Trust Company of Vermont's SALIX PHARMACEUTICALS LTD DEL position peaked at $35K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Trust Company of Vermont's 13F filing for Q2 2015, filed 16 Jul 2015.